Coagulopathy of COVID-19 and antiphospholipid antibodies.
作者信息
Connell Nathan T, Battinelli Elisabeth M, Connors Jean M
机构信息
Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
出版信息
J Thromb Haemost. 2020 Sep;18(9):E1-E2. doi: 10.1111/jth.14893. Epub 2020 May 28.
Abstract
摘要
相似文献
1
Coagulopathy of COVID-19 and antiphospholipid antibodies.新型冠状病毒肺炎的凝血功能障碍与抗磷脂抗体
J Thromb Haemost. 2020 Sep;18(9):E1-E2. doi: 10.1111/jth.14893. Epub 2020 May 28.
2
Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy.抗磷脂综合征的抗原和抗体作为 COVID-19 凝血障碍发病机制的新盟友。
Int J Mol Sci. 2022 Apr 29;23(9):4946. doi: 10.3390/ijms23094946.
3
Antiphospholipid Antibodies in Critically Ill Patients With COVID-19.COVID-19 重症患者的抗磷脂抗体。
Arthritis Rheumatol. 2020 Dec;72(12):1998-2004. doi: 10.1002/art.41425. Epub 2020 Oct 7.
4
Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study.COVID-19 患者入住重症监护病房时抗磷脂抗体的流行率和临床意义：一项前瞻性观察研究。
Rheumatol Int. 2021 Jul;41(7):1243-1252. doi: 10.1007/s00296-021-04875-7. Epub 2021 May 5.
5
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.原发性抗磷脂综合征患者接种 SARS-CoV-2 疫苗后的免疫原性、安全性和抗磷脂抗体。
Lupus. 2022 Jul;31(8):974-984. doi: 10.1177/09612033221102073. Epub 2022 May 20.
6
Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy.关于新冠病毒相关凝血病中抗磷脂抗体的现实核查
Arthritis Rheumatol. 2021 Jan;73(1):173-174. doi: 10.1002/art.41472. Epub 2020 Dec 5.
7
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.危重症 COVID-19 患者的天然抗凝剂、凝血因子和抗磷脂抗体谱。
J Thromb Thrombolysis. 2020 Oct;50(3):580-586. doi: 10.1007/s11239-020-02182-9.
8
Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?抗磷脂抗体是否会导致新冠病毒病中的凝血病？
J Am Acad Dermatol. 2020 Sep;83(3):e249. doi: 10.1016/j.jaad.2020.06.003. Epub 2020 Jun 4.
9
Antiphospholipid Antibodies and Infection: .抗磷脂抗体与感染： 。
Front Immunol. 2021 Jun 16;12:687534. doi: 10.3389/fimmu.2021.687534. eCollection 2021.
10
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
引用本文的文献
1
Is lupus anticoagulant testing with dilute Russell's viper venom clotting times reliable in the presence of inflammation?在存在炎症的情况下，采用稀释蝰蛇毒凝血时间进行狼疮抗凝物检测是否可靠？
Res Pract Thromb Haemost. 2024 Jul 26;8(6):102536. doi: 10.1016/j.rpth.2024.102536. eCollection 2024 Aug.
2
Cognitive dysfunctions in the course of SARS‑CoV‑2 virus infection, including NeuroCOVID, frontal syndrome and cytokine storm (Review).严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染过程中的认知功能障碍，包括神经型冠状病毒病、额叶综合征和细胞因子风暴（综述）
Biomed Rep. 2024 May 16;21(1):103. doi: 10.3892/br.2024.1791. eCollection 2024 Jul.
3
Emerging patterns of hypercoagulability associated with critical COVID-19: A review.与重症新型冠状病毒肺炎相关的高凝状态新趋势：综述
Trends Anaesth Crit Care. 2020 Oct;34:4-13. doi: 10.1016/j.tacc.2020.07.004. Epub 2020 Jul 9.
4
Lupus anticoagulants as a prospective independent predictor in COVID-19 patients.狼疮抗凝物作为 COVID-19 患者的前瞻性独立预测因子。
Int J Lab Hematol. 2023 Apr;45(2):163-169. doi: 10.1111/ijlh.14003. Epub 2022 Dec 10.
5
Tissue factor in COVID-19-associated coagulopathy.COVID-19 相关凝血病中的组织因子。
Thromb Res. 2022 Dec;220:35-47. doi: 10.1016/j.thromres.2022.09.025. Epub 2022 Oct 1.
6
Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review.新冠病毒感染患者的凝血功能障碍与血栓形成及涉及内皮细胞的可能机制：综述
Aging Dis. 2022 Feb 1;13(1):144-156. doi: 10.14336/AD.2021.0704. eCollection 2022 Feb.
7
Ischemic Priapism in a 12 Year Old Patient Associated With Coronavirus Disease 2019 (COVID-19): A Case Report.12 岁 COVID-19 患者并发缺血性阴茎异常勃起：病例报告
Urology. 2022 Jul;165:316-318. doi: 10.1016/j.urology.2022.01.022. Epub 2022 Jan 23.
8
Bilateral renal infarction with COVID-19 pneumonia: a case report.新型冠状病毒肺炎伴双侧肾梗死：一例报告
Oxf Med Case Reports. 2021 Dec 28;2021(11-12):omab121. doi: 10.1093/omcr/omab121. eCollection 2021 Nov-Dec.
9
COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications.COVID-19 与免疫血栓形成：病理生理学与治疗意义。
Crit Rev Oncol Hematol. 2021 Dec;168:103529. doi: 10.1016/j.critrevonc.2021.103529. Epub 2021 Nov 17.
10
Pathophysiology of Antiphospholipid Syndrome.抗磷脂综合征的病理生理学。
Thromb Haemost. 2022 Jul;122(7):1085-1095. doi: 10.1055/a-1701-2809. Epub 2021 Nov 18.
Zotero 插件